Both in vitro and cellular assays revealed that HBX 41,108 interferes with USP7-dependent p53 deubiquitination, leading to the activation of p53-responsive genes without inducing genotoxic stress or inhibiting the proliferation of cancer cells. The gene discussed is TP53; the disease is cancer.